Innate immunity and HCV

Journal of Hepatology

Volumn 58, Issue 3, 2013, Pages 564-574

  Heim, Markus H ^a,b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Hepatitis C virus; Innate immunity; Interferon; Jak STAT

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; DIFFERENTIATION ANTIGEN; GAMMA INTERFERON; INTERFERON REGULATORY FACTOR 3; INTERLEUKIN 28A; INTERLEUKIN 28B; INTERLEUKIN 29; MESSENGER RNA; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 2; PEGINTERFERON ALPHA2A PLUS RIBAVIRIN; PROTEIN INHIBITOR OF ACTIVATED STAT; STAT1 PROTEIN; STAT2 PROTEIN; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9;

ADAPTIVE IMMUNITY; ALLELE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONFORMATIONAL TRANSITION; CYTOKINE PRODUCTION; DNA RESPONSIVE ELEMENT; ENDOSOME; ENZYME ACTIVITY; GENE EXPRESSION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE MUTATION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INNATE IMMUNITY; INTERNAL RIBOSOME ENTRY SITE; LIMIT OF DETECTION; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LYMPHOCYTIC INFILTRATION; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION INITIATION; VIRAL CLEARANCE; VIRUS INTERFERENCE; VIRUS LOAD; VIRUS REPLICATION;

HEPACIVIRUS; HEPATITIS C; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; INTERFERONS; INTERLEUKINS; POLYMORPHISM, SINGLE NUCLEOTIDE; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 84874116578     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2012.10.005     Document Type: Review

References (116)

1. D. Lavanchy The global burden of hepatitis C Liver Int 29 2009 74 81
2. C.W. Shepard, L. Finelli, and M.J. Alter Global epidemiology of hepatitis C virus infection Lancet Infect Dis 5 2005 558 567
3. T. Santantonio, J. Wiegand, and J.T. Gerlach Acute hepatitis C: current status and remaining challenges J Hepatol 49 2008 625 633
4. G.M. Lauer, and B.D. Walker Hepatitis C virus infection N Engl J Med 345 2001 41 52
5. H.B. El-Serag Epidemiology of viral hepatitis and hepatocellular carcinoma Gastroenterology 142 2012 e1261
6. C. Kuiken, and P. Simmonds Nomenclature and numbering of the hepatitis C virus Methods Mol Biol 510 2009 33 53
7. M.B. Zeisel, I. Fofana, S. Fafi-Kremer, and T.F. Baumert Hepatitis C virus entry into hepatocytes: molecular mechanisms and targets for antiviral therapies J Hepatol 54 2011 566 576
8. D. Moradpour, F. Penin, and C.M. Rice Replication of hepatitis C virus Nat Rev 5 2007 453 463
9. EASL Clinical Practice Guidelines Management of hepatitis C virus infection J Hepatol 55 2011 245 264
10. M. Ghany, D.R. Nelson, D.B. Strader, D.L. Thomas, and L.B. Seeff An update on treatment of genotype 1 chronic hepatitis c virus infection: 2011 practice guidelines by the American association for the study of liver diseases Hepatology 54 2011 1433 1444
11. A.U. Neumann, N.P. Lam, H. Dahari, D.R. Gretch, T.E. Wiley, and T.J. Layden Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy Science 282 1998 103 107
12. D.B. Stetson, and R. Medzhitov Type I interferons in host defense Immunity 25 2006 373 381
13. A. Iwasaki, and R. Medzhitov Toll-like receptor control of the adaptive immune responses Nat Immunol 5 2004 987 995
14. S. Akira, S. Uematsu, and O. Takeuchi Pathogen recognition and innate immunity Cell 124 2006 783 801
15. M. Yoneyama, and T. Fujita Function of RIG-I-like receptors in antiviral innate immunity J Biol Chem 282 2007 15315 15318
16. M. Yoneyama, M. Kikuchi, T. Natsukawa, N. Shinobu, T. Imaizumi, and M. Miyagishi The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses Nat Immunol 5 2004 730 737
17. L. Alexopoulou, A.C. Holt, R. Medzhitov, and R.A. Flavell Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3 Nature 413 2001 732 738
18. S.S. Diebold, T. Kaisho, H. Hemmi, S. Akira, and C. Reis e Sousa Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA Science 303 2004 1529 1531
19. F. Heil, H. Hemmi, H. Hochrein, F. Ampenberger, C. Kirschning, and S. Akira Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8 Science 303 2004 1526 1529
20. S. Bauer, C.J. Kirschning, H. Hacker, V. Redecke, S. Hausmann, and S. Akira Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition Proc Natl Acad Sci U S A 98 2001 9237 9242
21. K. Hoshino, T. Sugiyama, M. Matsumoto, T. Tanaka, M. Saito, and H. Hemmi IkappaB kinase-alpha is critical for interferon-alpha production induced by Toll-like receptors 7 and 9 Nature 440 2006 949 953
22. E. Meylan, J. Curran, K. Hofmann, D. Moradpour, M. Binder, and R. Bartenschlager Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus Nature 437 2005 1167 1172
23. L.G. Xu, Y.Y. Wang, K.J. Han, L.Y. Li, Z. Zhai, and H.B. Shu VISA is an adapter protein required for virus-triggered IFN-beta signaling Mol Cell 19 2005 727 740
24. R.B. Seth, L. Sun, C.K. Ea, and Z.J. Chen Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3 Cell 122 2005 669 682
25. T. Kawai, K. Takahashi, S. Sato, C. Coban, H. Kumar, and H. Kato IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction Nat Immunol 6 2005 981 988
26. T. Marcello, A. Grakoui, G. Barba-Spaeth, E.S. Machlin, S.V. Kotenko, and M.R. MacDonald Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics Gastroenterology 131 2006 1887 1898
27. S.D. Der, A. Zhou, B.R. Williams, and R.H. Silverman Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays Proc Natl Acad Sci U S A 95 1998 15623 15628
28. M.T. Dill, Z. Makowska, F.H. Duong, F. Merkofer, M. Filipowicz, and T.F. Baumert Interferon-gamma-stimulated genes, but not USP18, are expressed in livers of patients with acute hepatitis C Gastroenterology 143 2012 e776
29. M. Sarasin-Filipowicz, E.J. Oakeley, F.H. Duong, V. Christen, L. Terracciano, and W. Filipowicz Interferon signaling and treatment outcome in chronic hepatitis C Proc Natl Acad Sci U S A 105 2008 7034 7039
30. U. Muller, U. Steinhoff, L.F. Reis, S. Hemmi, J. Pavlovic, and R.M. Zinkernagel Functional role of type I and type II interferons in antiviral defense Science 264 1994 1918 1921
31. J.E. Durbin, R. Hackenmiller, M.C. Simon, and D.E. Levy Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease Cell 84 1996 443 450
32. S. Dupuis, E. Jouanguy, S. Al-Hajjar, C. Fieschi, I.Z. Al-Mohsen, and S. Al-Jumaah Impaired response to interferon-alpha/beta and lethal viral disease in human STAT1 deficiency Nat Genet 33 2003 388 391
33. S.V. Kotenko, G. Gallagher, V.V. Baurin, A. Lewis-Antes, M. Shen, and N.K. Shah IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex Nat Immunol 4 2003 69 77
34. R.P. Donnelly, F. Sheikh, S.V. Kotenko, and H. Dickensheets The expanded family of class II cytokines that share the IL-10 receptor-2 (IL-10R2) chain J Leukoc Biol 76 2004 314 321
35. J.E. Darnell Jr. STATs and gene regulation Science 277 1997 1630 1635
36. M.H. Heim, I.M. Kerr, G.R. Stark, and J.E. Darnell Jr. Contribution of STAT SH2 groups to specific interferon signaling by the Jak-STAT pathway Science 267 1995 1347 1349
37. J.E. Darnell Jr., I.M. Kerr, and G.R. Stark Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins Science 264 1994 1415 1421
38. Z. Zhou, O.J. Hamming, N. Ank, S.R. Paludan, A.L. Nielsen, and R. Hartmann Type III interferon (IFN) induces a type I IFN-like response in a restricted subset of cells through signaling pathways involving both the Jak-STAT pathway and the mitogen-activated protein kinases J Virol 81 2007 7749 7758
39. D.L. Krebs, and D.J. Hilton SOCS proteins: negative regulators of cytokine signaling Stem Cells 19 2001 378 387
40. W.S. Alexander, R. Starr, J.E. Fenner, C.L. Scott, E. Handman, and N.S. Sprigg SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine Cell 98 1999 597 608
41. J.E. Fenner, R. Starr, A.L. Cornish, J.G. Zhang, D. Metcalf, and R.D. Schreiber Suppressor of cytokine signaling 1 regulates the immune response to infection by a unique inhibition of type I interferon activity Nat Immunol 7 2006 33 39
42. M.P. Malakhov, K.I. Kim, O.A. Malakhova, B.S. Jacobs, E.C. Borden, and D.E. Zhang High-throughput immunoblotting. Ubiquitin-like protein ISG15 modifies key regulators of signal transduction J Biol Chem 278 2003 16608 16613
43. M.P. Malakhov, O.A. Malakhova, K.I. Kim, K.J. Ritchie, and D.E. Zhang UBP43 (USP18) specifically removes ISG15 from conjugated proteins J Biol Chem 277 2002 9976 9981
44. L.Q. Liu, R. Ilaria Jr., P.D. Kingsley, A. Iwama, R.A. van Etten, and J. Palis A novel ubiquitin-specific protease, UBP43, cloned from leukemia fusion protein AML1-ETO-expressing mice, functions in hematopoietic cell differentiation Mol Cell Biol 19 1999 3029 3038
45. B. Skaug, and Z.J. Chen Emerging role of ISG15 in antiviral immunity Cell 143 2010 187 190
46. D. Zhang, and D.E. Zhang Interferon-stimulated gene 15 and the protein ISGylation system J Interferon Cytokine Res 31 2011 119 130
47. L. Chen, S. Li, and I. McGilvray The ISG15/USP18 ubiquitin-like pathway (ISGylation system) in hepatitis C virus infection and resistance to interferon therapy Int J Biochem Cell Biol 43 2011 1427 1431
48. D.J. Lenschow, C. Lai, N. Frias-Staheli, N.V. Giannakopoulos, A. Lutz, and T. Wolff IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses Proc Natl Acad Sci U S A 104 2007 1371 1376
49. C. Lai, J.J. Struckhoff, J. Schneider, L. Martinez-Sobrido, T. Wolff, and A. Garcia-Sastre Mice lacking the ISG15 E1 enzyme UbE1L demonstrate increased susceptibility to both mouse-adapted and non-mouse-adapted influenza B virus infection J Virol 83 2009 1147 1151
50. L. Chen, J. Sun, L. Meng, J. Heathcote, A.M. Edwards, and I.D. McGilvray ISG15, a ubiquitin-like interferon-stimulated gene, promotes hepatitis C virus production in vitro: implications for chronic infection and response to treatment J Gen Virol 91 2010 382 388
51. O.A. Malakhova, K.I. Kim, J.K. Luo, W. Zou, K.G. Kumar, and S.Y. Fuchs UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activity EMBO J 25 2006 2358 2367
52. K.J. Ritchie, M.P. Malakhov, C.J. Hetherington, L. Zhou, M.T. Little, and O.A. Malakhova Dysregulation of protein modification by ISG15 results in brain cell injury Genes Dev 16 2002 2207 2212
53. O.A. Malakhova, M. Yan, M.P. Malakhov, Y. Yuan, K.J. Ritchie, and K.I. Kim Protein ISGylation modulates the JAK-STAT signaling pathway Genes Dev 17 2003 455 460
54. K.J. Ritchie, C.S. Hahn, K.I. Kim, M. Yan, D. Rosario, and L. Li Role of ISG15 protease UBP43 (USP18) in innate immunity to viral infection Nat Med 10 2004 1374 1378
55. M. Sarasin-Filipowicz, X. Wang, M. Yan, F.H. Duong, V. Poli, and D.J. Hilton Alpha interferon induces long-lasting refractoriness of JAK-STAT signaling in the mouse liver through induction of USP18/UBP43 Mol Cell Biol 29 2009 4841 4851
56. Z. Makowska, F.H. Duong, G. Trincucci, D.F. Tough, and M.H. Heim Interferon-beta and interferon-lambda signaling is not affected by interferon-induced refractoriness to interferon-alpha in vivo Hepatology 53 2011 1154 1163
57. B. Liu, J. Liao, X. Rao, S.A. Kushner, C.D. Chung, and D.D. Chang Inhibition of Stat1-mediated gene activation by PIAS1 Proc Natl Acad Sci U S A 95 1998 10626 10631
58. B. Liu, S. Mink, K.A. Wong, N. Stein, C. Getman, and P.W. Dempsey PIAS1 selectively inhibits interferon-inducible genes and is important in innate immunity Nat Immunol 5 2004 891 898
59. R. Thimme, D. Oldach, K.M. Chang, C. Steiger, S.C. Ray, and F.V. Chisari Determinants of viral clearance and persistence during acute hepatitis C virus infection J Exp Med 194 2001 1395 1406
60. C.B. Bigger, K.M. Brasky, and R.E. Lanford DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection J Virol 75 2001 7059 7066
61. A.I. Su, J.P. Pezacki, L. Wodicka, A.D. Brideau, L. Supekova, and R. Thimme Genomic analysis of the host response to hepatitis C virus infection Proc Natl Acad Sci U S A 99 2002 15669 15674
62. M.E. Major, H. Dahari, K. Mihalik, M. Puig, C.M. Rice, and A.U. Neumann Hepatitis C virus kinetics and host responses associated with disease and outcome of infection in chimpanzees Hepatology 39 2004 1709 1720
63. H. Dahari, M. Major, X. Zhang, K. Mihalik, C.M. Rice, and A.S. Perelson Mathematical modeling of primary hepatitis C infection: noncytolytic clearance and early blockage of virion production Gastroenterology 128 2005 1056 1066
64. R. Thimme, J. Bukh, H.C. Spangenberg, S. Wieland, J. Pemberton, and C. Steiger Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease Proc Natl Acad Sci U S A 99 2002 15661 15668
65. M. Binder, F. Eberle, S. Seitz, N. Mucke, C.M. Huber, and N. Kiani Molecular mechanism of signal perception and integration by the innate immune sensor retinoic acid-inducible gene-I (RIG-I) J Biol Chem 286 2011 27278 27287
66. A. Schmidt, T. Schwerd, W. Hamm, J.C. Hellmuth, S. Cui, and M. Wenzel 5′-Triphosphate RNA requires base-paired structures to activate antiviral signaling via RIG-I Proc Natl Acad Sci U S A 106 2009 12067 12072
67. M. Schlee, A. Roth, V. Hornung, C.A. Hagmann, V. Wimmenauer, and W. Barchet Recognition of 5′ triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus Immunity 31 2009 25 34
68. T. Saito, D.M. Owen, F. Jiang, J. Marcotrigiano, and M. Gale Jr. Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA Nature 454 2008 523 527
69. G. Cheng, J. Zhong, and F.V. Chisari Inhibition of dsRNA-induced signaling in hepatitis C virus-infected cells by NS3 protease-dependent and -independent mechanisms Proc Natl Acad Sci U S A 103 2006 8499 8504
70. M. Binder, G. Kochs, R. Bartenschlager, and V. Lohmann Hepatitis C virus escape from the interferon regulatory factor 3 pathway by a passive and active evasion strategy Hepatology 46 2007 1365 1374
71. S. Marukian, L. Andrus, T.P. Sheahan, C.T. Jones, E.D. Charles, and A. Ploss Hepatitis C virus induces interferon-lambda and interferon-stimulated genes in primary liver cultures Hepatology 54 2011 1913 1923
72. E. Thomas, V.D. Gonzalez, Q. Li, A.A. Modi, W. Chen, and M. Noureddin HCV infection induces a unique hepatic innate immune response associated with robust production of type III interferons Gastroenterology 142 2012 978 988
73. H. Park, E. Serti, O. Eke, B. Muchmore, L. Prokunina-Olsson, and S. Capone IL-29 is the dominant type III interferon produced by hepatocytes during acute hepatitis C virus infection Hepatology 2012
74. K. Takahashi, S. Asabe, S. Wieland, U. Garaigorta, P. Gastaminza, and M. Isogawa Plasmacytoid dendritic cells sense hepatitis C virus-infected cells, produce interferon, and inhibit infection Proc Natl Acad Sci U S A 107 2010 7431 7436
75. E. Foy, K. Li, C. Wang, R. Sumpter Jr., M. Ikeda, and S.M. Lemon Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease Science 300 2003 1145 1148
76. K. Li, E. Foy, J.C. Ferreon, M. Nakamura, A.C. Ferreon, and M. Ikeda Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF Proc Natl Acad Sci U S A 102 2005 2992 2997
77. P. Bellecave, M. Sarasin-Filipowicz, O. Donze, A. Kennel, J. Gouttenoire, and E. Meylan Cleavage of mitochondrial antiviral signaling protein in the liver of patients with chronic hepatitis C correlates with a reduced activation of the endogenous interferon system Hepatology 51 2010 1127 1136
78. B. Langhans, B. Kupfer, I. Braunschweiger, S. Arndt, W. Schulte, and H.D. Nischalke Interferon-lambda serum levels in hepatitis C J Hepatol 54 2011 859 865
79. C. Neumann-Haefelin, and R. Thimme Success and failure of virus-specific T cell responses in hepatitis C virus infection Dig Dis 29 2011 416 422
80. J. Jo, U. Aichele, N. Kersting, R. Klein, P. Aichele, and E. Bisse Analysis of CD8+ T-cell-mediated inhibition of hepatitis C virus replication using a novel immunological model Gastroenterology 136 2009 1391 1401
81. C.B. Bigger, B. Guerra, K.M. Brasky, G. Hubbard, M.R. Beard, and B.A. Luxon Intrahepatic gene expression during chronic hepatitis C virus infection in chimpanzees J Virol 78 2004 13779 13792
82. M.T. Dill, F.H. Duong, J.E. Vogt, S. Bibert, P.Y. Bochud, and L. Terracciano Interferon-induced gene expression is a stronger predictor of treatment response than IL28B genotype in patients with hepatitis C Gastroenterology 140 2011 e1010
83. M. Honda, A. Sakai, T. Yamashita, Y. Nakamoto, E. Mizukoshi, and Y. Sakai Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C Gastroenterology 139 2010 499 509
84. T.J. Urban, A.J. Thompson, S.S. Bradrick, J. Fellay, D. Schuppan, and K.D. Cronin IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C Hepatology 52 2010 1888 1896
85. L. Chen, I. Borozan, J. Feld, J. Sun, L.L. Tannis, and C. Coltescu Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection Gastroenterology 128 2005 1437 1444
86. T. Asselah, I. Bieche, S. Narguet, A. Sabbagh, I. Laurendeau, and M.P. Ripault Liver gene expression signature to predict response to pegylated interferon plus ribavirin combination therapy in patients with chronic hepatitis C Gut 57 2008 516 524
87. M.H. Heim, D. Moradpour, and H.E. Blum Expression of hepatitis C virus proteins inhibits signal transduction through the Jak-STAT pathway J Virol 73 1999 8469 8475
88. A. Blindenbacher, F.H. Duong, L. Hunziker, S.T. Stutvoet, X. Wang, and L. Terracciano Expression of hepatitis c virus proteins inhibits interferon alpha signaling in the liver of transgenic mice Gastroenterology 124 2003 1465 1475
89. F.H. Duong, M. Filipowicz, M. Tripodi, N. La Monica, and M.H. Heim Hepatitis C virus inhibits interferon signaling through up-regulation of protein phosphatase 2A Gastroenterology 126 2004 263 277
90. U. Garaigorta, and F.V. Chisari Hepatitis C virus blocks interferon effector function by inducing protein kinase R phosphorylation Cell Host Microbe 6 2009 513 522
91. J.W. Schoggins, S.J. Wilson, M. Panis, M.Y. Murphy, C.T. Jones, and P. Bieniasz A diverse range of gene products are effectors of the type I interferon antiviral response Nature 472 2011 481 485
92. J.J. Feld, S. Nanda, Y. Huang, W. Chen, M. Cam, and S.N. Pusek Hepatic gene expression during treatment with peginterferon and ribavirin: Identifying molecular pathways for treatment response Hepatology 46 2007 1548 1563
93. D. Ge, J. Fellay, A.J. Thompson, J.S. Simon, K.V. Shianna, and T.J. Urban Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance Nature 461 2009 399 401
94. A. Rauch, Z. Kutalik, P. Descombes, T. Cai, J. Di Iulio, and T. Mueller Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study Gastroenterology 138 2010 1338 1345 1345 e1331-1337
95. D.L. Thomas, C.L. Thio, M.P. Martin, Y. Qi, D. Ge, and C. O'Huigin Genetic variation in IL28B and spontaneous clearance of hepatitis C virus Nature 461 2009 798 801
96. Y. Tanaka, N. Nishida, M. Sugiyama, M. Kurosaki, K. Matsuura, and N. Sakamoto Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C Nat Genet 41 2009 1105 1109
97. V. Suppiah, M. Moldovan, G. Ahlenstiel, T. Berg, M. Weltman, and M.L. Abate IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy Nat Genet 41 2009 1100 1104
98. HapMapConsortium A haplotype map of the human genome Nature 437 2005 1299 1320
99. V. Suppiah, M. Moldovan, G. Ahlenstiel, T. Berg, M. Weltman, and M.L. Abate IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy Nat Genet 41 2009 1100 1104
100. Y. Tanaka, N. Nishida, M. Sugiyama, M. Kurosaki, K. Matsuura, and N. Sakamoto Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C Nat Genet 41 2009 1105 1109
101. H.L. Tillmann, A.J. Thompson, K. Patel, M. Wiese, H. Tenckhoff, and H.D. Nischalke A polymorphism near IL28B is associated with spontaneous clearance of acute hepatitis C virus and jaundice Gastroenterology 139 2010 1586 1592 1592 e1581
102. T. Fukuhara, A. Taketomi, T. Motomura, S. Okano, A. Ninomiya, and T. Abe Variants in IL28B in liver recipients and donors correlate with response to peg-interferon and ribavirin therapy for recurrent hepatitis C Gastroenterology 139 2010 1577 1585 1585 e1571-1573
103. E. Cisneros, I. Banos, M.J. Citores, A. Duca, C. Salas, and A. Noblejas Increased risk of severe hepatitis C virus recurrence after liver transplantation in patients with a T allele of IL28B rs12979860 Transplantation 94 2012 275 280
104. A. Duarte-Rojo, B.J. Veldt, D.D. Goldstein, H.L. Tillman, K.D. Watt, and J.K. Heimbach The course of posttransplant hepatitis C infection: comparative impact of donor and recipient source of the favorable IL28B genotype and other variables Transplantation 94 2012 197 203
105. D. Eurich, S. Boas-Knoop, M. Ruehl, M. Schulz, E.D. Carrillo, and T. Berg Relationship between the interleukin-28b gene polymorphism and the histological severity of hepatitis C virus-induced graft inflammation and the response to antiviral therapy after liver transplantation Liver Transpl 17 2011 289 298
106. M.R. Charlton, A. Thompson, B.J. Veldt, K. Watt, H. Tillman, and J.J. Poterucha IL28B polymorphisms are associated with histological recurrence and treatment response following liver transplantation in patients with hepatitis C virus infection Hepatology 53 2010 317 324
107. M. Coto-Llerena, S. Perez-Del-Pulgar, G. Crespo, J.A. Carrion, S.M. Martinez, and J.M. Sanchez-Tapias Donor and recipient IL28B polymorphisms in HCV-infected patients undergoing antiviral therapy before and after liver transplantation Am J Transplant 11 2011 1051 1057
108. C.M. Lange, D. Moradpour, A. Doehring, H.A. Lehr, B. Mullhaupt, and S. Bibert Impact of donor and recipient IL28B rs12979860 genotypes on hepatitis C virus liver graft reinfection J Hepatol 55 2011 322 327
109. R.E. Randall, and S. Goodbourn Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures J Gen Virol 89 2008 1 47
110. R.E. Lanford, E.S. Hildebrandt-Eriksen, A. Petri, R. Persson, M. Lindow, and M.E. Munk Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection Science 327 2009 198 201
111. N. Akuta, F. Suzuki, M. Hirakawa, Y. Kawamura, H. Yatsuji, and H. Sezaki Amino acid substitution in hepatitis C virus core region and genetic variation near the interleukin 28B gene predict viral response to telaprevir with peginterferon and ribavirin Hepatology 52 2010 421 429
112. S. Zeuzem, P. Andreone, S. Pol, E. Lawitz, M. Diago, and S. Roberts Telaprevir for retreatment of HCV infection N Engl J Med 364 2011 2417 2428
113. I.M. Jacobson, J.G. McHutchison, G. Dusheiko, A.M. Di Bisceglie, K.R. Reddy, and N.H. Bzowej Telaprevir for previously untreated chronic hepatitis C virus infection N Engl J Med 364 2011 2405 2416
114. B.R. Bacon, S.C. Gordon, E. Lawitz, P. Marcellin, J.M. Vierling, and S. Zeuzem Boceprevir for previously treated chronic HCV genotype 1 infection N Engl J Med 364 2011 1207 1217
115. F. Poordad, J. McCone Jr., B.R. Bacon, S. Bruno, M.P. Manns, and M.S. Sulkowski Boceprevir for untreated chronic HCV genotype 1 infection N Engl J Med 364 2011 1195 1206
116. Z. Makowska, and M.H. Heim Interferon signaling in the liver during hepatitis C virus infection Cytokine 59 2012 460 466